An improved LC-MS/MS method for quantitative determination of ilaprazole and its metabolites in human plasma and its application to a pharmacokinetic study
about
Pharmacokinetic interactions between ilaprazole and clarithromycin following ilaprazole, clarithromycin and amoxicillin triple therapy.Effect of CYP2C19 genetic polymorphism on pharmacokinetics and pharmacodynamics of a new proton pump inhibitor, ilaprazole.Ilaprazole, a new proton pump inhibitor, is primarily metabolized to ilaprazole sulfone by CYP3A4 and 3A5
P2860
An improved LC-MS/MS method for quantitative determination of ilaprazole and its metabolites in human plasma and its application to a pharmacokinetic study
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
An improved LC-MS/MS method fo ...... ion to a pharmacokinetic study
@ast
An improved LC-MS/MS method fo ...... ion to a pharmacokinetic study
@en
An improved LC-MS/MS method fo ...... on to a pharmacokinetic study.
@nl
type
label
An improved LC-MS/MS method fo ...... ion to a pharmacokinetic study
@ast
An improved LC-MS/MS method fo ...... ion to a pharmacokinetic study
@en
An improved LC-MS/MS method fo ...... on to a pharmacokinetic study.
@nl
prefLabel
An improved LC-MS/MS method fo ...... ion to a pharmacokinetic study
@ast
An improved LC-MS/MS method fo ...... ion to a pharmacokinetic study
@en
An improved LC-MS/MS method fo ...... on to a pharmacokinetic study.
@nl
P2093
P2860
P356
P1476
An improved LC-MS/MS method fo ...... ion to a pharmacokinetic study
@en
P2093
Dong-sheng Ou-Yang
Han-wu Deng
Ying-zi Liu
Zhi-rong Tan
P2860
P2888
P304
P356
10.1038/APS.2009.120
P577
2009-08-24T00:00:00Z
P5875
P6179
1047330573